Neoadjuvant treatment for locally advanced unresectable and borderline resectable pancreatic cancer: oncological outcomes at a single academic centre

INTRODUCTION: Pancreatic cancer (PC), even in the absence of metastatic disease, has a dismal prognosis. One-third of them are borderline resectable (BRPC) or locally advanced unresectable PC (LAUPC) at diagnosis. There are limited prospective data supporting the best approach on these tumours. Neoa...

Descripción completa

Detalles Bibliográficos
Autores principales: Roselló, Susana, Pizzo, Claudio, Huerta, Marisol, Muñoz, Elena, Aliaga, Roberto, Vera, Almudena, Alfaro-Cervelló, Clara, Jordá, Esther, Garcés-Albir, Marina, Roda, Desamparados, Dorcaratto, Dimitri, Tarazona, Noelia, Torondel, Sergio, Guijarro, Jorge, Sánchiz, Vicente, Gambardella, Valentina, Fleitas-Kanonnikoff, Tania, Lluch, Paloma, Pascual, Isabel, Ferrández, Antonio, Sabater, Luis, Cervantes, Andrés
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684818/
https://www.ncbi.nlm.nih.gov/pubmed/33229503
http://dx.doi.org/10.1136/esmoopen-2020-000929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684818/
https://www.ncbi.nlm.nih.gov/pubmed/33229503
http://dx.doi.org/10.1136/esmoopen-2020-000929

Ejemplares similares